Navigation Links
Four Myths About Melanoma

BOSTON, Oct. 30, 2013 /PRNewswire/ -- When it comes to melanoma and other skin cancers, misconceptions abound. It is important to understand what will help prevent them and what might actually increase a person's risk. Here are four common myths related to melanoma and other skin cancers.

MYTH: Dark skin doesn't burn so those with it won't get skin cancer.

FACT: All skin types and ethnic groups can develop skin cancer. While it is true that Caucasians have a greater risk of skin-related cancer, everyone should protect their skin against UV rays. Although fair-skinned people can fairly easily see stage 1 melanoma and other cancers, darker skin makes catching it in the early stages more unlikely, and darker-skinned individuals tend to develop a more lethal type of melanoma that develops on the soles of the feet, between the toes, and on the palms of the hands. Additionally, Hispanics and African-Americans who have developed skin cancer have a noticeably higher mortality rate, often due to having it diagnosed in later stages.

MYTH: Putting on sunscreen as soon as one gets to the beach will protect against skin cancer.

FACT: Sunscreen takes about 15-30 minutes to really get absorbed by skin. Although it will still make a difference, a person won't have total protection until it has been absorbed. Additionally, applying sunscreen every two to four hours- and more frequently if you're in the water- while in the sun is highly recommended. Also, people should make sure to choose a broad-spectrum sunscreen with an SPF of 30, especially those with fair skin.

MYTH: Unexposed skin can't get melanoma and doesn't need to be checked.

FACT: Unfortunately, melanoma can be developed on the soles of feet, beneath toenails and fingernails, in some organs and even in the eyes. Whether skin is exposed or not, it is still at risk of melanoma and should be checked during a cancer screening.

MYTH: Only people who tan regularly get skin cancer.

FACT: Anyone can get melanoma or other skin-related cancers. If there are any signs that a mole is changing shape or color, or a patch of skin has become harder or discolored, a doctor should be consulted. If cancer is detected, it is important to keep abreast of the latest advances in detection and treatment.

For example, Caliber I.D., with facilities in Rochester and Boston, is currently the only company in the world to offer an FDA-cleared in vivo confocal microscope designed specifically for imaging skin and other tissue. Caliber I.D.'s Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye.

More than 15 years of engineering and development at US-based Caliber I.D. combined with feedback from independent researchers in the United States, Europe, and Australia, has resulted in the VivaScope, a robust suite of imaging products. The VivaScope® suite offers breakthrough technology that represents a new era in medical imaging. Physicians now have a cellular-level view of the patient's skin at the bedside, allowing for immediate tissue characterization and treatment. For those cases that require additional support from other specialists, Caliber I.D.'s telepathology system allows near real-time collaboration with remote specialists.

For more information, please visit, which paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210

SOURCE Caliber I.D.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens
2. New Study Debunks Wastage Myths of Prescriptions Filled in Medicare Part D
3. Leading Cardiologist Dispels the Myths about Dietary Supplement Niacin
4. New White Paper, "Five Biggest Myths about Medical Products Outsourcing," Finds OEMs Concerns are Often Unfounded
5. FDA 483s and Warning Letters list inadequate CAPA practices! What are Medical Device Manufacturers doing about it?
6. New Survey Reveals U.S. Men with Advanced Prostate Cancer Worry More about Burdening Family and Friends Than Dying
7. Many Women Not Warned About Mesh Implant Risks
8. Distinguished Health Group Speaks about Swissray Benefits
9. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
10. Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today
11. The World Customs Organization (WCO) and the Institute of Research Against Counterfeit Medicines (IRACM) issue a new warning about the health and safety of African populations
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... ATLANTA , Nov. 25, 2015 ... the first federal bellwether trial against Wright Medical ... relating to their Conserve metal-on-metal hip implant device, ... Christiansen.  Following a two week trial and three ... Conserve metal-on-metal hip device was defectively designed and ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and ... of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. ... 5.10 up-to-date with a version of Asterisk that will receive not only security ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced today that ... Somu now offers travelers, value and care based Travel Services, including exclusive pricing ... well as, cabin upgrades and special amenities such as, shore excursions, discounted fares, ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... medical opinion process, participated in the 61st annual Employee Benefits Conference. The Employee ... took place Sunday, November 8th through Wednesday, November 11th, 2015. The conference was ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... potentially more aggressive than those found on mammography, according to a study published ... of additional cancers not seen on mammography may necessitate a change in treatment. ...
Breaking Medicine News(10 mins):